A CT-based radiomics nomogram for differentiation of renal oncocytoma and chromophobe renal cell carcinoma with a central scar-matched study

被引:0
|
作者
Li, Xiaoli [1 ]
Ma, Qianli [2 ]
Nie, Pei [1 ]
Zheng, Yingmei [3 ]
Dong, Cheng [1 ]
Xu, Wenjian [1 ]
机构
[1] Qingdao Univ, Dept Radiol, Affiliated Hosp, Qingdao, Shandong, Peoples R China
[2] Qingdao Municipal Hosp, Dept Radiol, Qingdao, Shandong, Peoples R China
[3] Qingdao Univ, Affiliated Hosp, Hlth Management Ctr, Qingdao, Shandong, Peoples R China
来源
BRITISH JOURNAL OF RADIOLOGY | 2022年 / 95卷 / 1129期
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: Pre-operative differentiation between renal oncocytoma (RO) and chromophobe renal cell carcinoma (chRCC) is critical due to their different clinical behavior and different clinical treatment decisions. The aim of this study was to develop and validate a CT-based radiomics nomogram for the pre-operative differentiation of RO from chRCC.Methods: A total of 141 patients (84 in training data set and 57 in external validation data set) with ROs (n = 47) or chRCCs (n = 94) were included. Radiomics features were extracted from tri-phasic enhanced-CT images. A clinical model was developed based on significant patient characteristics and CT imaging features. A radiomics signature model was developed and a radiomics score (Rad-score) was calculated. A radiomics nomogram model incorporating the Rad-score and independent clinical factors was developed by multivariate logistic regression analysis. The diagnostic performance was evaluated and validated in three models using ROC curves.Results: Twelve features from CT images were selected to develop the radiomics signature. The radiomics nomogram combining a clinical factor (segmental enhancement inversion) and radiomics signature showed an AUC value of 0.988 in the validation set. Decision curve analysis revealed that the diagnostic performance of the radiomics nomogram was better than the clinical model and the radiomics signature.Conclusions: The radiomics nomogram combining clinical factors and radiomics signature performed well for distinguishing RO from chRCC.Advances in knowledge: Differential diagnosis between renal oncocytoma (RO) and chromophobe renal cell carcinoma (chRCC) is rather difficult by conventional imaging modalities when a central scar was present. A radiomics nomogram integrated with the radiomics signature, demographics, and CT findings facilitates differentiation of RO from chRCC with improved diagnostic efficacy. The CT-based radiomics nomogram might spare unnecessary surgery for RO.Advances in knowledge: Differential diagnosis between renal oncocytoma (RO) and chromophobe renal cell carcinoma (chRCC) is rather difficult by conventional imaging modalities when a central scar was present. A radiomics nomogram integrated with the radiomics signature, demographics, and CT findings facilitates differentiation of RO from chRCC with improved diagnostic efficacy. The CT-based radiomics nomogram might spare unnecessary surgery for RO.Advances in knowledge: Differential diagnosis between renal oncocytoma (RO) and chromophobe renal cell carcinoma (chRCC) is rather difficult by conventional imaging modalities when a central scar was present. A radiomics nomogram integrated with the radiomics signature, demographics, and CT findings facilitates differentiation of RO from chRCC with improved diagnostic efficacy. The CT-based radiomics nomogram might spare unnecessary surgery for RO.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma
    Geramizadeh, Bita
    Ravanshad, Mahmoud
    Rahsaz, Marjan
    [J]. INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2008, 51 (02) : 167 - 171
  • [42] A CT-based deep learning radiomics nomogram outperforms the existing prognostic models for outcome prediction in clear cell renal cell carcinoma: a multicenter study
    Nie, Pei
    Yang, Guangjie
    Wang, Yanmei
    Xu, Yuchao
    Yan, Lei
    Zhang, Mingxin
    Zhao, Lianzi
    Wang, Ning
    Zhao, Xia
    Li, Xianjun
    Cheng, Nan
    Wang, Yicong
    Chen, Chengcheng
    Wang, Nan
    Duan, Shaofeng
    Wang, Ximing
    Wang, Zhenguang
    [J]. EUROPEAN RADIOLOGY, 2023, 33 (12) : 8858 - 8868
  • [43] Clear cell renal cell carcinoma: CT-based radiomics features for the prediction of Fuhrman grade
    Shu, Jun
    Tang, Yongqiang
    Cui, Jingjing
    Yang, Ruwu
    Meng, Xiaoli
    Cai, Zhengting
    Zhang, Jingsong
    Xu, Wanni
    Wen, Didi
    Yin, Hong
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2018, 109 : 8 - 12
  • [44] A CT-Based Radiomics Approach for the Differential Diagnosis of Sarcomatoid and Clear Cell Renal Cell Carcinoma
    Meng, Xiaoli
    Shu, Jun
    Xia, Yuwei
    Yang, Ruwu
    [J]. BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [45] CT-based peritumoral radiomics signatures for malignancy grading of clear cell renal cell carcinoma
    Zhiyong Zhou
    Xusheng Qian
    Jisu Hu
    Xinwei Ma
    Shoujun Zhou
    Yakang Dai
    Jianbing Zhu
    [J]. Abdominal Radiology, 2021, 46 : 2690 - 2698
  • [46] CT-based radiomics model for the prediction of genomic alterations in renal cell carcinoma (RCC)
    Ebrahimi, Hedyeh
    Lu, Kun-Han
    Castro, Daniela V.
    Mercier, Benjamin D.
    Dizman, Nazli
    Barragan-Carrillo, Regina
    Govindarajan, Ameish
    Meza, Luis
    Chawla, Neal S.
    Hsu, Joann
    Chehrazi-Raffle, Alexander
    Tripathi, Abhishek
    Liu, Sandy
    Dorff, Tanya B.
    Wong, Chi Wah
    Pal, Sumanta K.
    Zengin, Zeynep B.
    [J]. ONCOLOGIST, 2023, 28
  • [47] FDG PET/CT of Chromophobe Renal Cell Carcinoma With Sarcomatoid Differentiation
    Lee, Chee H.
    Kesari, Vivek
    Legesse, Teklu
    Chen, Wengen
    [J]. CLINICAL NUCLEAR MEDICINE, 2018, 43 (05) : 367 - 369
  • [48] Decoding Kidney Tumours: A Comparative Study of Immunohistochemical Markers in Renal Oncocytoma and Chromophobe Renal Cell Carcinoma
    Shaker, G.
    [J]. BRITISH JOURNAL OF SURGERY, 2024, 111
  • [49] CT-based peritumoral radiomics signatures for malignancy grading of clear cell renal cell carcinoma
    Zhou, Zhiyong
    Qian, Xusheng
    Hu, Jisu
    Ma, Xinwei
    Zhou, Shoujun
    Dai, Yakang
    Zhu, Jianbing
    [J]. ABDOMINAL RADIOLOGY, 2021, 46 (06) : 2690 - 2698
  • [50] Utility of cytokeratin 7 for distinguishing chromophobe renal cell carcinoma from renal oncocytoma
    Leroy, X
    Moukassa, D
    Copin, MC
    Saint, F
    Mazeman, E
    Gosselin, B
    [J]. EUROPEAN UROLOGY, 2000, 37 (04) : 484 - 487